Early presentation of de novo high grade glioma with epileptic seizures: electroclinical and neuroimaging findings  by Rossi, Rosario et al.
Seizure 19 (2010) 470–474Early presentation of de novo high grade glioma with epileptic seizures:
electroclinical and neuroimaging ﬁndings
Rosario Rossi a,*, Andrea Figus b, Simona Corraine b
aUnit of Neurology, San Francesco Hospital, via Mannironi, 08100 Nuoro, Italy
b Service of Radiology, San Francesco Hospital, via Mannironi, 08100 Nuoro, Italy
A R T I C L E I N F O
Article history:
Received 21 January 2010
Accepted 1 July 2010
Keywords:
Malignant glioma
High grade
Early presentation
Seizure
Neuroimaging
PLEDs
A B S T R A C T
We report the clinical, EEG and neuroradiologic ﬁndings from three adult patients who developed new-
onset seizuredisordersasearlyclinicalmanifestationsofdenovohighgradeglioma. Themalignancies could
not be recognised at the time of the ﬁrst epileptic seizure because of minimal non-speciﬁc brain
abnormalities, which showed no signs of necrosis or signiﬁcant contrast enhancement on computed
tomography and magnetic resonance imaging. Focal EEG abnormalities were recorded in all cases and
appeared consistent with the neuroradiologic ﬁndings. The patients regained normal neurological status
after the ﬁrst seizure but rapidly developed space-occupying necrotic lesions. Two patients underwent
surgery and received histological diagnoses of the tumours. Another patient was ﬁnally diagnosed with a
malignantgliomabasedontheneuroradiologicpictureandrapidprogressionof thecerebral lesion. It should
benoted that inadult patients, new-onset epileptic seizuresmight reveal thepresenceofmalignant gliomas
at a very early stage in the tumour formation process. This report indicates that typical anatomoradiologic
features of de novo high grade glioma, such as necrosis and rim-contrast enhancement, could be absent at
the time of the ﬁrst epileptic seizure but become clear within a short period after clinical presentation.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epileptic seizures are a frequent clinical manifestation of
cerebral malignant (high grade) glioma.1–3 Actually, the large
majority of patientswith new-onset neurologic symptoms related
to this malignancy are identiﬁed by radiologic evidence of
necrotic masses with rim-contrast enhancement and perilesional
oedema. These neuroimaging ﬁndings are usually associatedwith
an unfavourable prognosis quoad vitam in the short term, as the
median survival time of patients with high grade glioma, even
after surgery, radiotherapy and chemotherapy, is approximately
22 months for anaplastic astrocytoma and 12 months for
glioblastoma.4 In a subgroup of patients, however, the clinical
presentation of malignant glioma might coincide with the very
early stage of the tumoural process in the event that neuroimaging
studies indicate minimal non-enhancing brain abnormalities or
even fail to reveal any sign of the tumour.5,6 In this case, the
diagnosis of glioma can be easily missed, with signiﬁcant
consequences for the patient’s prognosis. Conventional magnetic
resonance imaging (MRI) has signiﬁcantly improved the visuali-
sation of small non-enhancing brain tumours, that might not be
detectable with computed tomography (CT). Further, the devel-* Corresponding author. Tel.: +39 0784 240203; fax: +39 0784 240212.
E-mail address: rosario.rossi@aslnuoro.it (R. Rossi).
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doi:10.1016/j.seizure.2010.07.001opment of diffusion-weighted (DWI) and perfusion-weighted
imaging (PWI) has made it possible to investigate speciﬁc
anatomoradiologic features of gliomas, such as cellularity and
vascularity, which have recently been proposed as predictors of
tumour grade.7–11 Metabolic studies with positron emission
tomography (PET) have also demonstrated a pathogenic relation-
ship between radio-marked glucose and amino acid uptake and
grading.12,13 Despite the increasing amount of information
obtained from neuroimaging of brain tumours, early-stage high
grade gliomas lack speciﬁc radiologic characteristics and timely
identiﬁcation of these malignancies remains challenging.
2. Materials and methods
We reviewed the clinical, EEG and neuroimaging ﬁndings from
three adult patients (a 75-year-old man and two women, aged 58
and 68, respectively), who presented to the hospital with new-
onset seizure disorders as early clinical manifestations of de novo
high grade gliomas. Plain and gadolinium-enhanced MRI of the
brain was performed on all patients, using a 1-Tesla MRI system.
Two patients also underwent a brain CT scan without contrast
material. Diagnosis of gliomas could not bemade at the time of the
ﬁrst epileptic seizure because of minimal non-speciﬁc brain
abnormalities that did not show signs of necrosis or signiﬁcant
contrast enhancement on the imaging studies. All patients were
discharged from the hospital with normal neurological status butvier Ltd. All rights reserved.
Table 1
Early clinical, EEG and neuroimaging ﬁndings from three patients with de novo high grade gliomas.
Age/sex Seizure type (symptoms) EEG CT (ﬁgure) MRI (ﬁgure) Histopathology (site of lesion)
75/M GTCS, focal (confused mental
status, speech deﬁcit, right
hemiclonic jerks)
PLEDs, focal
theta-delta
slowing
Hyperdense area,
marginal
hypodensity (1)
T2, FLAIR, PD hyperintensities,
signs of gyral swelling,
non-enhancing (2)
Not determined,
imaging consistent
with glioblastoma
(left middle
temporal gyrus)
58/F Focal (disturbance of
consciousness, leftward
deviation of head and trunk, fall)
Focal theta-delta
slowing
Not performed T2, FLAIR, PD hyperintensities,
T1 hypointense spot,
non-enhancing (3)
III grade anaplastic
oligodendroglioma
(right middle temporal gyrus)
68/F Focal (disorientation,
speech disturbance) secondarily
generalised
Focal SW+ theta
slowing
Hyperdense area,
marginal hypodensity
(not shown)
T2, FLAIR hyperintensities,
signs of gyral swelling,
tiny nodular enhancement (4)
Glioblastoma (left TPO crossway)
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tumourswere obtained after surgery in two cases. In the other case,
the malignant glioma was ﬁnally diagnosed using the neuroradio-
logic picture and rapid progression of the cerebral lesion.
3. Results
The seizure type, EEG and neuroimaging ﬁndings are sum-
marised in Table 1. In all cases, new-onset epileptic seizures
heralded the clinical manifestation of the malignancies. A general-
ised tonic–clonic seizure (GTCS) was ﬁrstly reported in one patient,
who alsodeveloped abrupt confusionwith speechdisturbances, and
subsequent right hemiclonic seizure 3 weeks later. In this case,
mental and speech function returned to normal after 5 days. Acute
mental abnormalities in the formof spatial disorientationassociated
with speechdeﬁcit, followedby aGTCSwere also described as initial
symptoms in one of the other cases. Another patient presentedwith
abrupt impairment of consciousness, leftward deviation of the head
and trunk, and subsequently fell to the ground. All patients regained
normal neurological status after the ﬁrst seizure, without recalling
the epileptic symptomatology.
In two cases, brain CT scans without contrast material revealed
a small hyperdense abnormality with mild peripheral hypodensity
in the left lateral temporal region (Fig. 1a and b) and temporo-
parieto-occipital (TPO) crossway (not shown), respectively. In one
of these cases, such abnormality was triangular in shape, and
mimicked a haemorrhagic infarction (Fig. 1b).
In all patients, the MRI revealed indistinct areas of signal
hyperintensity on T2-weighted, ﬂuid-attenuated inversion recov-Fig. 1. (a and b) Plain CT scan performed after the ﬁrst seizure: hyperdense lesion with mery (FLAIR) and proton density (PD) images (Figs. 2a–c, 3a–c, and
4a–c) with similar distribution to that seen on the CT scans in two
cases. T1-weighted MRI did not provide signiﬁcant information,
with the exception of a tiny spot of signal hypointensity that was
observed in the right middle temporal gyrus of one patient
(Fig. 3c). A gyral swelling was detected in two cases. This feature
was best visualised on FLAIR and PD images, the latter
demonstrating the major involvement of the cortex (Fig. 2b).
The administration of gadolinium did not enhance the abnormali-
ties seen in two patients, while there was evidence of a tiny
nodular contrast enhancement in the left TPO crossway in the
other case (Fig. 4c).
Focal EEG abnormalities including periodic lateralised epilepti-
formdischarges (PLEDs), sharpwaves (SW) and theta-delta slowing,
were reported for all patients and appeared consistent with the
neuroimaging ﬁndings. The EEG abnormalities were recorded after
full recovery from ictal symptoms, with the exception of PLEDs,
which were detected before the regression of the state of confusion
withspeechdisturbances. In this case,PLEDswereno longerpresent,
as they were replaced by irregular theta-delta activity on another
EEG recorded 5 days after the onset ofmental and speech disorders,
when the patient was already asymptomatic.
In two cases, subsequent MRI examinations indicated enhanc-
ing space-occupying lesions (Figs. 3d and 4d) 2 months after the
ﬁrst seizure when both patients still showed normal neurological
status. The histopathology of tumours, according to the classiﬁca-
tion of the World Health Organization,14 was obtained after
surgery and revealed a grade III anaplastic oligodendroglioma and
a glioblastoma, respectively. Another patient came back to thearginal hypodensity, mimicking a haemorrhagic infarction in the left temporal lobe.
Fig. 3. (a–c) MRI at clinical onset: FLAIR (a) and PD (b) images show a tiny area of signal hyperintensity in the right middle temporal gyrus. (c) T1-weighted image: spot of
signal hypointensity in the same area. (d) Gadolinium-enhancedMRI after 2months: necrotic lesionwithmural nodule and rim-contrast enhancement, expression of III grade
anaplastic oligodendroglioma.
Fig. 4. (a–c) MRI at clinical onset: FLAIR (a) and T2-weighted (b) images indicate hyperintense abnormalities in the left TPO region. (c) Tiny nodular contrast enhancement
after gadolinium. (d) Post-contrast T1-weighted MRI after 2 months: evidence of glioblastoma.
Fig. 2. (a–c) MRI at clinical onset: FLAIR (a) and PD (b) images indicate a gyral swelling in the left temporal lobe. T2-weighted image (c) shows a signal hyperintensity in the
same area. (d) Post-contrast T1-weighted MRI performed 5 months later: necrotic mass with irregular contrast enhancement, consistent with glioblastoma.
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progressive speech deﬁcits. Subsequent MRI studies revealed a left
temporal necrotic mass with irregular contrast enhancement and
perilesional oedema that appeared consistent with glioblastoma
(Fig. 2d). In this case, the initial CT (Fig. 1a and b) and MRI ﬁndings
(Fig. 2a–c) had previously resulted unchanged in a second
neuroimaging study that was performed 2 months after the ﬁrst
seizure. This patient refused surgery and died of tumour
progression shortly after the radiologic diagnosis of malignant
glioma. The patients whowere operated on showed relapses of the
malignancies and died 1 year after surgery.
4. Discussion
These results illustrated the clinical, EEG and neuroimaging
characteristics of seizures related to cerebral malignant gliomas at
a very early stage of tumoural growth and documented the
neuroradiologic progression of the malignancies from minimal,non-speciﬁc, brain abnormalities to more consistent radiologic
features. It is known that high grade gliomas can develop as de novo
lesions or derive from the secondary transformation of low grade
tumours.15,16 In the latter case, the anaplastic transformation
usually occurs after a variable period of years,15 when patients have
already become symptomatic and the low grade lesion has been
identiﬁed.16 Different from such anatomoclinical course, the rapid
progression of small cerebral abnormalities during a period of few
weeks in these patients indicated that these malignancies arose as
de novo high grade lesions. These ﬁndings are in agreement with
previous reports, which demonstrated that de novo high grade
gliomas could result fromnon-enhancing abnormalities and rapidly
develop into necrotic masses with rim-contrast enhancement.6,17
Despite the major incidence of epileptic disorders in patients
with low grade gliomas,1,3,18,19 seizures are a distinctive clinical
manifestation of early-stage high grade tumours.5,6,17 In these
patients, seizures were similarly related to localisations of glioma
in the lateral temporal region, with additional participation of the
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involvement of the cortex. While it has not been demonstrated that
early clinical presentation of cerebral tumours corresponds to
speciﬁc brain localisations, it is reasonable that the tumoural
inﬁltration of the cortex may result in earlier onset of symptoms,
particularly seizures2,20 and possibly focal neurologic deﬁcits, if the
malignancy develops in eloquent areas of the brain. Localisations in
the cortico-medullary junction actually predominated in a series of
patients with small gliomas,21 while a superﬁcial tumoural origin
has been described in cases of glioblastoma with early clinical
presentation.22 Further, the cortical involvement on the lateral
surfaceof thebrain couldexplain the timelyexpressionof signiﬁcant
EEG abnormalities, regardless of the small size of lesions.
Particularly for the patients who developed acute mental abnor-
malities and speech disturbances, the EEG provided important clues
about the site of lesion, indicating a symptomatic epileptic
localisation in the left temporal region. In one of these patients,
the prolonged alteration of speech and mental function could be
entirely attributed to thepresenceof PLEDs, an ictal EEGpattern that
has already been reported in patients with confusion of epileptic
origin.23 In fact, the regression of neurologic symptoms coincided
with the disappearance of this EEG pattern, despite the underlying
parenchymal lesion.Although the ictal EEGcouldnotbe recorded for
another patient who exhibited similar alterations in mental and
speech functionwith consequentGTCS, the clinical and EEGﬁndings
equally suggesteda focal seizure disorder,withmajor disturbanceof
the left temporal lobe and secondary generalisation. In this case,
mental status and speech returned to normal rapidly after the
seizure, when the EEG recorded interictal abnormalities in the form
of focal theta slowing and SW. Our ﬁndings indicated that confused
mental states with disturbances of speech might characterise the
symptomatology of seizure disorders related to localisation of
malignant glioma in the lateral temporal region of the dominant
hemisphere. In this case, PLEDs could be recorded during the ictal
period and occasionally be responsible for prolonged alteration of
mental and speech function.
MRI is consideredmore sensitive than CT in detecting small non-
enhancing cerebral tumours.5 In this regard, it is notable that
parenchymal abnormalities with similar radiologic characteristics
could be identiﬁed with CT in two patients. Apart from the
peripheral hypodensity of these lesions that might be attributed to
mild oedema, the interpretation of the hyperdense appearance of
the gliomas on CT remains uncertain. Cerebral lesions with
hyperdense characteristics on plain CT usually correspond to
calciﬁcation or haemorrhagic damage. Although the use of MRI
might be less valuable in these circumstances, the overall MRI
results couldnot conﬁrmanyof these typesofparenchymaldamage.
In fact, areas with absence of signal or signiﬁcant hypointensity on
T1 and T2-weighted images (as in the case of calciﬁcation) or
hyperintensity on T1-weighted images usually observed during the
follow-up of haemorrhagic lesions, were not reported for the
patients that underwent both CT and MRI. An increased cellularity
and vascularisation of the tumoural lesion due to the high grading of
gliomacouldexplain themanifestationofhyperdenseabnormalities
on plain CT scans. Anatomical characteristics of these initial lesions,
however, cannot be demonstrated without histological data or
additional information from more advanced neuroradiologic
techniques such as perfusion-CT,24 DWI, and PWI.7–11 Further
information is also necessary to clarify whether the hyperdense
appearance of small tumoural lesions seen by plain CT might
represent an early radiologic feature of glioblastoma.
The MRI ﬁndings were mainly characterised by indistinct areas
of signal hyperintensity on T2-weighted, FLAIR and PD images,
with signs of gyral swelling in two cases. On these sequences,
signal hyperintensities usually indicate increased water content in
the cerebral parenchyma, a non-speciﬁc alteration that mightresult from brain damage of various aetiologies. Considering that
oedema and the solid portion of malignant glioma cannot be
clearly differentiated with any of these sequences, the exact
extension of non-enhancing tumours, as in these cases, can be
difﬁcult to determine with conventional MRI. Although the
radiologic borders of malignant glioma are generally referred to
as rim-contrast enhancement, the neuropathology of high grade
lesions demonstrated that inﬁltration by neoplastic cells can be
found beyond these limits, in areaswith T2 signal hyperintensity,14
and even in the parenchyma free of radiologic abnormalities.25 It is
unclear to what extent such invasion of the parenchyma can occur
during the early stage of malignant glioma formation. In these
cases, however, the detection of radiologic abnormalities with
indistinct margins (Figs. 2a and 4a) could be a sign of early
aggressive behaviour of these tumours, as inﬁltration of the
parenchyma could have preceded the development of necrosis and
the disruption of the blood–brain-barrier.
Plain T1-weighted MRI ﬁndings were limited to the tiny area of
signal hypointensity pictured in Fig. 3c, that could be interpreted as
tumoural microcyst or initial necrosis. Despite the minimal
appearance of this feature, its signiﬁcance as an early radiologic
sign of de novo high grade glioma formation is consistent with
previous ﬁndings. In fact, the development of a small, central cyst
before the emergence of contrast enhancement has been demon-
strated during the early stage of high grade astrocytic lesions.26
The radiologic presentation of tumours with non-enhancing
abnormalities in two of these cases reﬂected the substantial
integrity of the blood–brain-barrier during the initial phase of the
process. It has been demonstrated, however, that the mainte-
nance of the blood–brain-barrier is usually brief in malignant
glioma, as the vast majority of patients with early-stage high
grade tumours developed enhancing necrotic masses within 6
months from the initial symptomatology.5,6,17,22 The information
available suggests that the neuroradiologic follow-up of uncer-
tain brain abnormalities should be carried out throughout such
period on adult patients with new-onset seizure disorders.
Regarding the rapid progression of these early neoplastic lesions,
we believe that neuroimaging studies should be repeated at
intervals of 1 month at least during the ﬁrst 3-month-period, if
the tumoural aetiology of new-onset seizures cannot be excluded
with additional investigations. Indeed, the radiologic changes
depicted in Fig. 3 indicate that consistent imaging features can
unexpectedly appear a few weeks after the discovery of tiny
unremarkable abnormalities. Neuroimaging studies with DWI,
PWI, PET and magnetic resonance spectroscopy, which are
currently included in the diagnostic work-up of brain tumours,
might provide useful information for pre-operatively determin-
ing the tumour grade.7–11,15 To our best knowledge, however,
there is no evidence that these investigations effectively lead to
early surgery ofmalignant glioma, if conventional MRI has not yet
demonstrated consistent abnormalities.
Although the information available is insufﬁcient to delineate a
speciﬁc clinicoradiologic proﬁle of patients with early presentation
of de novo high grade glioma, it must be stressed that new-onset
seizure disorders might reveal the initial stage of this malignancy.
Biopsy of indeﬁnite brain abnormalities should be constantly
considered for adult patients with newly diagnosed epileptic
seizures. Nonetheless, the neuroradiologic surveillance at short
intervals might be crucial for timely identiﬁcation of de novo high
grade glioma, with the purpose of achieving the best possible
treatment and prognosis.
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